Substrate Imaging Before Catheter Ablation of Ventricular Tachycardia: Risk Prediction for Acute Hemodynamic Decompensation

JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 3):1684-1693. doi: 10.1016/j.jacep.2023.03.023. Epub 2023 Jun 21.

Abstract

Background: The PAINESD (Pulmonary disease, Age, Ischemic cardiomyopathy, NYHA functional class, Ejection fraction, Storm, Diabetes mellitus) risk score has been validated as a predictor of periprocedural acute hemodynamic decompensation (AHD) in patients undergoing ventricular tachycardia (VT) ablation. Whether the addition of total scar volume (TSV) determined by preprocedure computed tomography imaging provides additional risk stratification has not been previously investigated.

Objectives: The purpose of this study was to evaluate the impact of TSV on the risk of AHD and its adjunctive benefit to the PAINESD score newly modified as Pulmonary disease, Age, Ischemic cardiomyopathy, NYHA class, Ejection fraction, Storm, Scar volume, Diabetes mellitus (PAINES2D) based on the addition of scar volumes.

Methods: This was a retrospective analysis of all index VT ablations at a quaternary care center from 2017 to 2022. Associations between TSV and AHD were evaluated among patients with structural heart disease.

Results: Among 61 patients with TSV data, 13 (21%) had periprocedural AHD. TSV and PAINESD were independently associated with AHD risk. Both TSV and PAINESD were associated with AHD (P = 0.016 vs P = 0.053, respectively). The highest TSV tertile (≥37.30 mL) showed significant association with AHD (P = 0.018; OR: 4.80) compared to the other tertiles. The PAINESD and PAINES2D scores had significant impact on AHD (P = 0.046 and P = 0.010, respectively). The PAINES2D score had a greater impact on AHD compared to PAINESD (area under the curve: 0.73; P = 0.011; 95% CI: 0.56-0.91 and area under the curve: 0.67; P = 0.058; 95% CI: 0.49-0.85, respectively).

Conclusions: Addition of TSV to a modified PAINESD score, PAINES2D, enhances risk prediction of AHD. Further prospective study is needed to assess benefit in various cardiomyopathy populations undergoing VT ablation.

Keywords: catheter ablation; hemodynamic decompensation; scar volume; ventricular tachycardia.

MeSH terms

  • Aged
  • Catheter Ablation* / adverse effects
  • Catheter Ablation* / methods
  • Cicatrix / complications
  • Cicatrix / diagnostic imaging
  • Female
  • Hemodynamics* / physiology
  • Humans
  • Male
  • Retrospective Studies
  • Risk Assessment
  • Tachycardia, Ventricular* / diagnostic imaging
  • Tachycardia, Ventricular* / physiopathology
  • Tachycardia, Ventricular* / surgery
  • Tomography, X-Ray Computed